study question: Is the presence of adenomyosis associated with menorrhagia? summary answer: There was no significant association between adenomyosis and menorrhagia, but there was a significant positive correlation between the severity of adenomyosis on ultrasound and the amount of menstrual loss estimated using pictorial blood loss assessment charts.
Introduction
Adenomyosis is a benign condition of the uterus, defined by the presence of endometrial glands and stroma within the myometrium. There is no consensus on the depth of endometrial penetration required for a histological diagnosis of adenomyosis with proposed depths including one low-power field, one high-power field, .25% of total myometrial thickness and a depth .2.5 mm. Original descriptions of the disease showed an association between adenomyosis and heavy and prolonged periods (Cullen, 1908) . Several later studies reported similar findings (Benson and Sneedon, 1958; Emge, 1962; Bird et al., 1972) , but others have not shown significant differences in the prevalence of adenomyosis between women with and without a history of menorrhagia (Parazzini et al., 1997; Levgur et al., 2000; Bergholt et al., 2001; Weiss et al., 2009) . Most of these studies used retrospective histological examination of hysterectomy specimens to diagnose adenomyosis and compare it with clinical symptoms. The main problem with the use of histology for the diagnosis of adenomyosis in these studies is the heavy selection bias incurred (Mehasseb and Habiba, 2009) . Furthermore, in retrospective studies it is very difficult to account for confounding variables such as concomitant uterine fibroids which have an independent adverse effect on menstrual periods (Wegienka et al., 2003) .
Transvaginal ultrasound has recently been used for the non-invasive diagnosis of adenomyosis (Kepkep et al., 2007) and to study its prevalence (Naftalin et al., 2012) . There have been no large scale prospective studies using non-invasive techniques to assess the link between adenomyosis and clinical symptoms. The aim of this study was to investigate the possible association between adenomyosis and heavy menstrual periods.
Materials and Methods
This was a prospective observational study of premenopausal women attending our general gynaecology clinic. Women were considered to be premenopausal if they had passed menarche but had not yet reached the menopause. In all women, a detailed clinical history was taken prior to undertaking the ultrasound scan. Women were asked about frequency and duration of menstrual periods and about any episodes of intermenstrual or postcoital bleeding. The amount of menstrual loss was assessed subjectively by asking whether they felt their periods were excessively heavy or not. We also asked a subgroup of women to complete a pictorial blood loss analysis chart (PBAC) in order to obtain more objective information about the amount of menstrual loss. PBACs use a scoring system to calculate total menstrual loss that accounts for both the number of sanitary towels or tampons a woman uses during her period and also the degree to which each item is soiled. They have been shown to have a high specificity and sensitivity when used as a diagnostic test for objective menorrhagia (Higham et al., 1990) . Women were advised to complete the chart during their next period and then to return it back to the department by post (a stamped addressed envelope was provided). A transvaginal ultrasound scan was then carried out using a 4 -9 MHz probe with three-dimensional facility (Voluson E8, GE Medical Systems, Milwaukee, WI, USA). All transvaginal ultrasound scans were performed by a single operator (J.N.) in standardized fashion as follows: first the uterus was examined in the transverse plane to identify the cervical canal and the uterine cavity. The probe was then rotated 908 anti-clockwise and the uterus and endometrium were visualized in the longitudinal plane. Fibroids were diagnosed based on direct visualization using previously described diagnostic criteria (Anderson, 1999) . The criteria for ultrasound diagnosis of adenomyosis have been previously reported. Briefly, the diagnosis of adenomyosis was made if one of more of the following features were present: asymmetrical myometrial thickening, myometrial cysts, linear striations, parallel shadowing, adenomyomas, hyperechoic islands and an irregular endometrial -myometrial junction on either B-mode or three-dimensional imaging (Naftalin et al., 2012) . Endometrial polyps were diagnosed based on direct visualization using previously described criteria (Timmerman et al., 2003) .
Women who were unable to undergo a transvaginal scan or had previously undergone a hysterectomy and those with a history of amenorrhoea or oligomenorrhoea with a cycle length .60 days were excluded from the study. Women using contraceptives or taking medications that would affect menstrual flow, women who attended for ultrasound scan during their IVF cycle and those who underwent hysterectomy prior to their next period following the scan were not asked to complete a PBAC (Fig. 1) Statistical analysis was performed in two stages, first for subjective assessment of menorrhagia and then for objective assessment of menstrual loss. Regression methods were used to examine possible associations between various demographic and clinical variables and menorrhagia. The subjective measure was a binary outcome, and so the analysis of this outcome was performed using logistic regression. The PBAC scores were measured on a Figure 1 Flowchart describing patient inclusion. (PBAC, pictorial blood loss analysis chart.) continuous scale, and so linear regression was used for the analysis. The scores were found to have a heavily positively skewed distribution, and thus were given a log transformation before analysis.
The analyses themselves were performed in two stages. Initially, the separate association of each factor with the outcome was examined in a series of univariable analyses. Subsequently the joint effect of the variables upon each outcome was assessed in a multivariable analysis. To limit the number of variables in this analysis, only factors with a univariable P-value of ,0.2 were considered for this stage of the analysis. A backwards selection procedure was used to retain only the statistically significant variables in the final model. As menstrual loss was analysed on a log scale, the results are summarized in the form of ratios whereby the ratios represent the PBAC values when the symptoms were present relative to when it was absent. A Kappa analysis was used to analyse the agreement between the subjective assessment of menorrhagia and the PBACs, where a PBAC score of ≥100 was considered to be consistent with menorrhagia.
Statistical analysis was performed, using the SPSS software (SPSS, Inc., Chicago, IL, USA). Ethical approval was sought from and approved by the local research ethics committee who deemed that full ethical approval was not required.
Results
A total of 892 consecutive premenopausal women attended for clinic visits between January 2009 and January 2010. One hundred and seventy-eight women were excluded ( Fig. 1 ) and 714 were entered into the data analysis. Their median age was 38 Tables II and III. A diagnosis of adenomyosis was made in 157/714 women [22.0%]. In 100/ 157 [63.7% (95% CI: 55.9-70.1%)] of these women, adenomyosis was the only uterine abnormality seen. All 714 women were entered into data analysis for subjective menstrual loss. Five hundred and twenty-nine women were asked to complete PBACs and the analysis of objective assessment of menstrual loss was performed in the 304 women who returned their charts (Fig. 1 ). There was moderately good agreement between subjective and objective assessment of menstrual loss where a PBAC score of ≥100 was considered to be consistent with menorrhagia (k ¼ 0.529; 95% CI: 0.435-0.623) (Table IV) . There was no significant difference between responders and non-responders in age, BMI, gravidity, parity and self-reported menorrhagia (P . 0.05).
The results of the univariable analysis examining the associations of demographic and clinical variables with subjective assessment of menorrhagia are shown in Table V . The multivariable analysis for subjective assessment (Table VI) showed that BMI, gravidity, fibroids, in particular submucous fibroids and endometrial polyps, were all significantly associated with menorrhagia. The univariable analysis examining the associations of demographic and clinical variables with objective menstrual loss can be seen in Table VII . The multivariable analysis for objective menstrual loss showed that gravidity, fibroids, in particular submucous fibroids and endometrial polyps, were all significantly associated with menorrhagia (Table VIII) . Adenomyosis, when assessed as a binary outcome, was not significantly associated with subjective assessment of menorrhagia or objective menstrual loss. There was, however, a significant positive correlation between the number of features of adenomyosis on ultrasound scan and the volume of menstrual loss expressed as a PBAC score with each additional feature of adenomyosis being associated with an average 22% [95% CI: 6-42% (P ¼ 0.005)] increase in the PBAC value (Fig. 2) . Two further multivariable analyses were performed to compare the number of different morphological features of adenomyosis recorded on ultrasound in individual women and the presence of subjectively assessed menorrhagia. The first showed a significant positive relationship between the number of ultrasound features of adenomyosis and menstrual loss (Table IX , Model 1). The second multivariable analysis (Table IX, Model 2) compared women with no adenomyosis, women with ,4 and those with ≥4 ultrasound features of adenomyosis. This analysis showed women with ≥4 ultrasound features of adenomyosis, but not women with ,4 ultrasound features of adenomyosis, were significantly more likely to suffer with menorrhagia. A breakdown of the number of ultrasound features of adenomyosis recorded seen in the study population can be seen in Table X .
Discussion
Our results did not show a significant association between the presence of adenomyosis and menorrhagia on multivariable analysis. However, there was a statistically significant association between severity of adenomyosis and heavy menstrual loss. associated with menorrhagia included fibroids, in particular submucous fibroids, endometrial polyps, gravidity and BMI. Submucous fibroids were found to have the strongest association with menorrhagia.
The main strength of our study was that ultrasound rather than histology was used to diagnose uterine pathology, which helped to reduce selection bias. This also allowed the inclusion of a relatively large number of women with a greater range of symptoms and varying degrees of severity of adenomyosis who are likely, therefore, to be more representative of the population of women attending gynaecology clinics. In addition, this was a prospective study with clearly defined inclusion criteria and a standardized approach to the ultrasound examinations that were all performed by a single highly trained operator using advanced, modern ultrasound equipment. The use of a subjective assessment of menorrhagia is consistent with recent national guidance (NICE, 2007) for clinicians, while the use of PBACs allowed menstrual loss to be assessed as a continuous variable, therefore accounting for severity of menorrhagia. There was a good level of agreement between subjective and objective assessment of menorrhagia, so we used both methods to assess the severity of menorrhagia in this study.
There is a lack of consensus in the literature regarding the relationship between adenomyosis and menorrhagia. This is not surprising bearing in mind that the majority of studies were retrospective in nature and mainly included populations of women undergoing hysterectomy. These studies used differing criteria for the diagnosis of adenomyosis and few of them attempted to quantify severity of disease. In addition, none of the studies controlled for the presence of concomitant pathology and their potential effect on the volume of menstrual loss. Our study has clearly shown that severity of adenomyosis correlates with the amount of menstrual loss. The severity of adenomyosis is difficult to express in quantitative terms as the lesions are often poorly defined and they may be disseminated throughout different parts of the myometrium. Levgur et al. (2000) used depth of foci of adenomyosis on histological examination to assess severity of disease in their retrospective study. While this study had relatively small numbers and used retrospective case note analysis to define menorrhagia, it was still able to uncover an association between severity of adenomyosis and menorrhagia. We think that it is better to express severity of adenomyosis semi-quantitatively using the number of different morphological features in an individual woman as an indirect measure of severity of disease. The recognition that the severity of a condition is important when assessing clinical impact has already been adopted in clinical practice when studying the effect of fibroids on menstrual loss. It has been generally accepted that size and location of fibroids determines their clinical significance (NICE, 2007) . Our study has also confirmed that the location of fibroids is a critical diagnostic feature as submucous fibroids were found to have a much more severe effect on menstrual loss than fibroids in other locations.
Other variables found to be associated with menorrhagia in our study include endometrial polyps, increasing gravidity and increasing BMI. Endometrial polyps are frequently cited as a cause of menorrhagia (Dreisler et al., 2009 ) with interventional studies showing that hysteroscopic polypectomies significantly reduced menstrual loss as measured by PBACs (van Dongen et al., 2009) . While there is little data assessing the effect of increasing BMI on menorrhagia, it is known that the peripheral conversion of adrenal and gonadal androgens to estrogens in peripheral tissue is greater in obese women (Siiteri, 1987) . The increased endometrial proliferation caused by this estrogen excess is known to progress to endometrial hyperplasia and endometrial cancer. Endometrial proliferation would also be expected to cause increased menstrual flow. Our study cannot explain the association between increasing gravidity and menorrhagia, but it may be due to the increase in uterine size seen with increasing numbers of pregnancies (Verguts et al., 2013) .
There is no consensus in the literature on the relationship between adenomyosis and menorrhagia and our results indicate that it may be more complex than previously thought. The extent of the disease and the number of morphological features in individual patients may be as important as simply noting the presence or absence of adenomyosis. In view of this, it is important that future assessment of adenomyosis using ultrasound should at least attempt to identify individual features of disease when addressing women with menstrual symptoms. These findings should be interpreted in the context of concomitant uterine pathology in order to determine the most likely cause of women's symptoms. Further advances in three-dimensional scanning and elastography may provide tools to quantify the percentage of uterine muscle that is affected by adenomyosis, which may help to improve assessment of the severity of the disease. The use of a quantitative or semi-quantitative approach to the assessment of adenomyosis may be helpful in future clinical trials assessing efficacy of novel management strategies for treating adenomyosis and associated symptoms. It may also help provide new information on the relationship between adenomyosis and subfertility.
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